The 20 Best Oligodendroglioma Doctors in The United States

Patrick Wen is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Wen is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Wen is board certified in Neurology and Neuro-Oncology.

Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, and Brain Tumor. Dr. Holdhoff is board certified in American Board Of Internal Medicine.

David Peereboom is an Oncologist and a Hematologist Oncology provider practicing medicine in Cleveland, Ohio. Dr. Peereboom is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioblastoma, Glioma, Astrocytoma, and Bone Marrow Aspiration. Dr. Peereboom is board certified in United Council For Neurological Subspecialties, 2008.

"Michael Schulder, MD, is the vice chair of neurosurgery at North Shore University Hospital and Long Island Jewish Medical Center. He is also the director of the Brain Tumor Center at the Institute for Neurology and Neurosurgery-which treats more than 600 patients annually-and co-director of the Center for Stereotactic Radiosurgery, where his team offers the latest treatment technologies. His research focuses on improving methods of image guidance for brain tumor surgery, and on new techniques for radiosurgery.""I've always been fascinated by the workings of the brain and how it gives rise to our thoughts, memories and personalities in ways that aren't fully understood,"" Dr. Schulder says. He attended medical school at Columbia University College of Physicians and Surgeons, and completed his residency in neurological surgery at the Albert Einstein College of Medicine. Dr. Schulder also trained in stereotactic neuro-oncology at the University of Florida and the Brigham and Women's Hospital.Dr. Schulder works with neuro-oncologists, radiation oncologists and other neurosurgeons to create evidence-based treatment plans. ""We offer close multidisciplinary collaboration to help avoid delay in seeing patients,"" he says. The team strives to offer minimally invasive treatments as often as possible.With a keen interest in neurosurgical image guidance-the use of real-time images of the brain to make procedures safer and more precise-Dr. Schulder is studying the next generation of intraoperative MRI. He runs a brain tumor clinical trials program, giving his patients ready access to innovative approaches to care. While performing complex neurosurgery is one of the most satisfying parts of Dr. Schulder's job, ""empathizing with patients and their families throughout treatment is equally fulfilling,"" he says.In addition to treating brain tumors, Dr. Schulder performs functional neurosurgery to manage pain conditions like trigeminal neuralgia, and movement disorders including essential tremor and Parkinson's disease. He is the program director of neurosurgical residency training at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Schulder is active in organized neurosurgery, where among other offices he is past president of the World Society for Stereotactic and Functional Neurosurgery, director-at-large of the American Association of Neurological Surgeons, and historian of the American Academy Neurological Surgery.". Dr. Schulder is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 32 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Oligodendroglioma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Schulder is board certified in American Board Of Neurological Surgery.

Chetan Bettegowda is the director of the Johns Hopkins Department of Neurosurgery. He offers comprehensive treatments for adult patients with benign and malignant brain tumors, specializing in the treatment of patients with primary brain tumors such as gliomas, meningiomas and pituitary tumors. He performs both open surgery and stereotactic radiosurgery for patients with metastatic tumors to the brain, and also provides stereotactic radiosurgery for other neurological disorders, including spinal tumors, trigeminal neuralgia and skull-base tumors. Dr. Bettegowda is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 38 other conditions, according to our data. His clinical expertise encompasses Trigeminal Neuralgia, Astrocytoma, Glioblastoma, Rhizotomy, and Microvascular Decompression. Dr. Bettegowda is board certified in American Board Of Neurological Surgery.

Erik Uhlmann is a Neurologist practicing medicine in Boston, Massachusetts. Dr. Uhlmann is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Metastatic Brain Tumor, Brain Tumor, Astrocytoma, Glioblastoma, and Gamma Knife Radiosurgery. Dr. Uhlmann is board certified in American Board Of Pathology.

Nina Paleologos is a Psychiatrist and a Neurologist practicing medicine in Downers Grove, Illinois. Dr. Paleologos is rated as a Distinguished provider by MediFind in the treatment of Oligodendroglioma. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Oligodendroglioma, Glioma, Glioblastoma, and Astrocytoma. Dr. Paleologos is board certified in American Board Of Psychiatry & Neurology.

Anthony Asher is a Neurosurgery provider practicing medicine in Charlotte, North Carolina. Dr. Asher is rated as a Distinguished provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Spondylolisthesis, Cervical Myelopathy, Brain Tumor, Laminectomy, and Spinal Fusion. Dr. Asher is board certified in American Board Of Neurological Surgery. Dr. Asher is currently accepting new patients.

David Reardon is a Hematologist Oncology specialist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Reardon is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is board certified in Pediatric Hematology-Oncology and Pediatrics.

Andrew B. Lassman, MD, FAAN, FASCO, is a Professor of Neurology and Associate Dean of Clinical Research Compliance at the Columbia University Vagelos College of Physicians and Surgeons. Dr. Lassman also serves as Chief of the Division of Neuro-Oncology and Vice Chair for Clinical Research in the Department of Neurology, and as Associate Director for Clinical Trials at the Herbert Irving Comprehensive Cancer Center. As a clinician-scientist, Dr. Lassman focuses both his research and clinical efforts on improving the understanding and treatment of brain tumors.Dr. Lassman has particular expertise in translational clinical trials for brain tumors, with molecular correlative analyses to understand the reasons for treatment success or failure, and to refine treatment paradigms. Dr. Lassman has led retrospective studies, single institution prospective clinical trials, and multicenter prospective trials conducted nationally through the National Cancer Institute sponsored National Clinical Trials Network. His contributions to the field of Neuro-Oncology have been recognized with numerous awards, including the Preuss Award in Neuro-Oncology from the American Academy of Neurology, the Boyer Clinical Research Award from Memorial Sloan-Kettering Cancer Center, and the Gary Lichtenstein Humanitarian Award from Voices Against Brain Cancer.Dr. Lassman earned his BS and MS degrees in Molecular Biophysics and Biochemistry, as part of a combined four-year program at Yale University. He attained his MD from Columbia University College of Physicians and Surgeons and completed Neurology residency at the Neurological Institute of New York, at NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman completed his fellowship in Neuro-Oncology at Memorial Sloan-Kettering Cancer Center, where he joined the faculty and served as fellowship director, until his return to NewYork-Presbyterian/Columbia University Irving Medical Center. Dr. Lassman is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, and Gliomatosis Cerebri. Dr. Lassman is board certified in Neurology. Dr. Lassman is currently accepting new patients.

Dr. Jennie Taylor specializes in caring for adults with primary brain tumors, or tumors that start in the brain. As a member of the UCSF Brain Tumor Research Center, she is involved in developing new treatment strategies, innovative imaging techniques and comprehensive tumor analyses, with the goal of improving outcomes for patients with brain tumors. Taylor's research interests include analyzing molecular and imaging markers of resistance to current standard treatments for brain tumors. She also focuses on improving quality of life for patients with primary brain tumors as well as for their caregivers. Taylor earned her medical degree from the University of Kentucky College of Medicine. She completed an internship in medicine and a residency in neurology at the University of Virginia. She completed a fellowship in neuro-oncology at Massachusetts General Hospital and the Dana-Farber Cancer Institute while earning a master's degree in public health from the Harvard T.H. Chan School of Public Health. Taylor is a member of the American Academy of Neurology, Society for Neuro-Oncology and American Society of Clinical Oncology. Dr. Taylor is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Glioma, Astrocytoma, Brain Tumor, and Glioblastoma. Dr. Taylor is board certified in American Board Of Psychiatry/Neurology-Neurology, Neurology. Dr. Taylor is currently accepting new patients.

Dr. Shawn Hervey-Jumper is a neurosurgeon specializing in the treatment of patients with brain tumors, including low- and high-grade gliomas, meningiomas, brain metastases and neurocutaneous syndromes. Hervey-Jumper's research investigates how brain tumors violate important areas of the brain that affect how we move, speak and think. He also explores strategies to promote brain recovery and repair. In addition, he researches ways to map the human brain during surgery with the goal of limiting injury to key functional areas. Hervey-Jumper received his medical degree from the Ohio State University College of Medicine. He completed both a residency in neurosurgery and a fellowship in neuro-oncology at the University of Michigan. He then completed a clinical fellowship in neuro-oncology at UCSF. Hervey-Jumper is a member of the Society for Neuro-Oncology, American Association for Cancer Research, North American Skull Base Society, American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS). He is also a member of the joint section on tumors for the latter organizations. He is an associate professor in residence of neurological surgery at UCSF. Dr. Hervey is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glioma, Brain Tumor, Astrocytoma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Hervey is board certified in American Board Of Neurological Surgery, Neurological Surgery. Dr. Hervey is currently accepting new patients.

Andrew Tsung is a Neurosurgery provider practicing medicine in Peoria, Illinois. Dr. Tsung is rated as a Distinguished provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Tsung is board certified in American Board Of Neurological Surgery.

Dr. Kyle Work joined the Cancer Centers of Colorado at St. Mary?s Medical Center oncology team in 2018. He is a hematologist-oncologist. Dr. Work treats all types of cancers with a special interest in head and neck cancer, lung cancer and genitourinary cancers.Dr. Work is originally from Tulsa, Oklahoma where he graduated from the University of Tulsa with a degree in biology, and earned his medical degree at Oklahoma State University. He then moved to Kansas City where he completed his internal medicine residency and hematology / oncology fellowship at the University of Kansas Health System. During his hematology and oncology fellowship, he served as chief fellow for two years.Dr. Work is an investigator involved in clinical research trials in the area of hematology and medical oncology. His clinical research focus includes head and neck cancers, brain and lung cancers. When he is not working, he enjoys mountain biking, camping, and hiking with his wife and golden retrievers. Dr. Work is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. Dr. Work is board certified in American Board Of Internal Medicine. Dr. Work is currently accepting new patients.

Berkeley Bate is a Neurosurgery provider practicing medicine in Saint George, Utah. He has been practicing medicine for over 18 years. Dr. Bate is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Subdural Hematoma, Spinal Stenosis, Chronic Subdural Hematoma, Laminectomy, and Microdiscectomy. Dr. Bate is board certified in American Board Of Neurological Surgery. Dr. Bate is currently accepting new patients.

Dr. Sui earned a medical degree from Qingdao University, China, and a Ph.D. from the University of Tokyo, Japan. He conducted postdoctoral research in hematology at Vanderbilt University, an internal medicine residency at the University of Tennessee, and a medical oncology fellowship at the Fred Hutchinson Cancer Research Center and the University of Washington. He is board certified in internal medicine and medical oncology. He was an associate professor at Shangdong. Dr. Sui believes in treating his patients as if they were his own family members. Dr. Sui is rated as an Advanced provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 51 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Lung Cancer, Pleuropulmonary Blastoma, and Large-Cell Immunoblastic Lymphoma. Dr. Sui is board certified in American Board Of Internal Medicine. Dr. Sui is currently accepting new patients.

John De Groot is a Neurologist practicing medicine in San Francisco, California. Dr. De Groot is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Timothy Cloughesy is a Neurologist practicing medicine in Los Angeles, California. Dr. Cloughesy is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Camilo Fadul is an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Fadul is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Oligodendroglioma, Glioma, Astrocytoma, and Brain Tumor.

Manmeet Ahluwalia is an Oncologist practicing medicine in Miami, Florida. Dr. Ahluwalia is rated as an Elite provider by MediFind in the treatment of Oligodendroglioma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Glioblastoma, Astrocytoma, and Glioma. Dr. Ahluwalia is currently accepting new patients.